Information card for entry 1549665
Chemical name |
2-Methyl-4-(pyridin-2-yl)-3<i>H</i>-1,5-benzodiazepine |
Formula |
C15 H13 N3 |
Calculated formula |
C15 H13 N3 |
SMILES |
N1=C(CC(=Nc2ccccc12)c1ncccc1)C |
Title of publication |
2-Methyl-4-(pyridin-2-yl)-3<i>H</i>-1,5-benzodiazepine |
Authors of publication |
El Ghayati, Lhoussaine; Ramli, Youssef; Moussaif, Ahmed; Koubachi, Jamal; Taha, Mohamed Labd; Essassi, El Mokhtar; Mague, Joel T. |
Journal of publication |
IUCrData |
Year of publication |
2018 |
Journal volume |
3 |
Journal issue |
7 |
Pages of publication |
x180953 |
a |
5.9642 ± 0.0006 Å |
b |
17.7004 ± 0.0017 Å |
c |
11.3963 ± 0.0011 Å |
α |
90° |
β |
100.695 ± 0.001° |
γ |
90° |
Cell volume |
1182.2 ± 0.2 Å3 |
Cell temperature |
100 ± 2 K |
Ambient diffraction temperature |
100 ± 2 K |
Number of distinct elements |
3 |
Space group number |
14 |
Hermann-Mauguin space group symbol |
P 1 21/n 1 |
Hall space group symbol |
-P 2yn |
Residual factor for all reflections |
0.0616 |
Residual factor for significantly intense reflections |
0.0425 |
Weighted residual factors for significantly intense reflections |
0.1027 |
Weighted residual factors for all reflections included in the refinement |
0.1084 |
Goodness-of-fit parameter for all reflections included in the refinement |
0.973 |
Diffraction radiation wavelength |
0.71073 Å |
Diffraction radiation type |
MoKα |
Has coordinates |
Yes |
Has disorder |
No |
Has Fobs |
Yes |
For the version history of this entry, please navigate to main COD server.
The link is:
https://www.crystallography.net/1549665.html